Revance Therapeutics, Inc. (NASDAQ:RVNC) Q1 2021 Results Conference Call May 10, 2021 4:30 PM ET Company Participants Jessica Serra - Head, IR and ESG Mark Foley - President and CEO Toby Schilke - CFO Dr. Abhay Joshi - COO and President, R&D and Product Operations Dustin Sjuts - Chief Commercial Officer, Aesthetics and Therapeutics Aubrey Rankin - President, Innovation and Technology Conference Call Participants Ken Cacciatore - Cowen & Company Seamus Fernandez - Guggenheim Terence Flynn - Goldman Sachs Ann ...